Please use this identifier to cite or link to this item:
Title: Metabolomic identification of novel biomarkers of nasopharyngeal carcinoma
Authors: Yi, LZ
Dong, NP
Shi, ST
Deng, BC
Yun, YH
Yi, ZB
Zhang, Y
Issue Date: 2014
Publisher: Royal Society of Chemistry
Source: RSC advances, 2014, v. 4, no. 103, p. 59094-59101 How to cite?
Journal: RSC advances 
Abstract: This paper introduces a new identification strategy of novel metabolic biomarkers for nasopharyngeal carcinoma (NPC). Here, we combined gas chromatography-mass spectrometry (GC-MS) metabolic profiling with three partial least squares-discriminant analysis (PLS-DA) based variable selection methods to screen the metabolic biomarkers of NPC. We found that the variable importance on projection (VIP) method exhibited better efficiency than the coefficients beta and the loadings plot for the metabolomics data set of 39 NPC patients and 40 healthy controls. In addition, we proved that the area under receiver operating characteristic curve (AUC) was more sensitive than the correct rate to evaluate the discrimination ability of the classical models. Therefore, three novel candidate biomarkers, glucose, glutamic acid and pyroglutamate were identified, with a correct rate of 97.47% and an AUC value of 97.40%. Our results suggested that the metabolic disorders of NPC were mainly reflected in the glycolysis and glutamate metabolism; in addition, metabolic levels of the related metabolic pathways may affect each other, such as the TCA cycle and lipid metabolism. We believe that the findings of these novel metabolites will be very helpful for early-diagnosis and subsequent pathogenesis research of NPC.
EISSN: 2046-2069
DOI: 10.1039/c4ra09860a
Appears in Collections:Journal/Magazine Article

View full-text via PolyU eLinks SFX Query
Show full item record

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.